title: Reply to Seligman et Al.
authors.affiliation: Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston.
authors.forename: Klemen
authors.initials: K
authors.lastname: Strle
authors.affiliation: Department of Infectious Diseases, University Medical Center Ljubljana, Slovenia.
authors.forename: Daša
authors.initials: D
authors.lastname: Stupica
authors.affiliation: Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston.
authors.forename: Elise E
authors.initials: EE
authors.lastname: Drouin
authors.affiliation: Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston.
authors.forename: Allen C
authors.initials: AC
authors.lastname: Steere
authors.affiliation: Department of Infectious Diseases, University Medical Center Ljubljana, Slovenia.
authors.forename: Franc
authors.initials: F
authors.lastname: Strle
mesh_terms: D015787:Erythema Chronicum Migrans / Q000276:immunology*; D005260:Female; D006801:Humans; D053759:Interleukin-23 / Q000097:blood*; D008297:Male
chemical_list: D053759:Interleukin-23